PHIA Stock Overview
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for PHIA from our risk checks.
Koninklijke Philips N.V. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €19.75 |
52 Week High | €22.18 |
52 Week Low | €16.48 |
Beta | 0.78 |
1 Month Change | 5.12% |
3 Month Change | -6.20% |
1 Year Change | 8.07% |
3 Year Change | -56.00% |
5 Year Change | -44.27% |
Change since IPO | 1,605.72% |
Recent News & Updates
Recent updates
Here's Why Koninklijke Philips (AMS:PHIA) Has A Meaningful Debt Burden
Mar 21Lacklustre Performance Is Driving Koninklijke Philips N.V.'s (AMS:PHIA) Low P/S
Jan 21Does Koninklijke Philips (AMS:PHIA) Have A Healthy Balance Sheet?
Dec 16Koninklijke Philips (AMS:PHIA) Is Making Moderate Use Of Debt
Sep 17Is There Now An Opportunity In Koninklijke Philips N.V. (AMS:PHIA)?
Jul 16Is There An Opportunity With Koninklijke Philips N.V.'s (AMS:PHIA) 47% Undervaluation?
Jun 12Health Check: How Prudently Does Koninklijke Philips (AMS:PHIA) Use Debt?
Mar 30Shareholder Returns
PHIA | NL Medical Equipment | NL Market | |
---|---|---|---|
7D | 4.7% | 1.1% | 2.6% |
1Y | 8.1% | 0.9% | 17.5% |
Return vs Industry: PHIA exceeded the Dutch Medical Equipment industry which returned 0.9% over the past year.
Return vs Market: PHIA underperformed the Dutch Market which returned 17.5% over the past year.
Price Volatility
PHIA volatility | |
---|---|
PHIA Average Weekly Movement | 3.1% |
Medical Equipment Industry Average Movement | 5.8% |
Market Average Movement | 3.7% |
10% most volatile stocks in NL Market | 7.8% |
10% least volatile stocks in NL Market | 2.3% |
Stable Share Price: PHIA has not had significant price volatility in the past 3 months.
Volatility Over Time: PHIA's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1891 | 69,656 | Roy Jakobs | www.philips.com |
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Koninklijke Philips N.V. Fundamentals Summary
PHIA fundamental statistics | |
---|---|
Market cap | €17.90b |
Earnings (TTM) | -€456.00m |
Revenue (TTM) | €18.17b |
1.0x
P/S Ratio-39.2x
P/E RatioIs PHIA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PHIA income statement (TTM) | |
---|---|
Revenue | €18.17b |
Cost of Revenue | €10.72b |
Gross Profit | €7.45b |
Other Expenses | €7.90b |
Earnings | -€456.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 29, 2024
Earnings per share (EPS) | -0.50 |
Gross Margin | 40.99% |
Net Profit Margin | -2.51% |
Debt/Equity Ratio | 54.8% |
How did PHIA perform over the long term?
See historical performance and comparison